CompletedPHASE1, PHASE2NCT01710644
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Studying Cystic fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Nordmark Arzneimittel GmbH & Co. KG
- Principal Investigator
- Kristin Forssmann, MDNordmark Arzneimittel GmbH & Co. KG
- Intervention
- Burlulipase(drug)
- Enrollment
- 35 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2013 – 2014
Study locations (9)
- Nemours Children's Clinic, Jacksonville, Florida, United States
- Nemours Children's Clinic, Pensacola, Florida, United States
- The University of Iowa, Iowa City, Iowa, United States
- Via Cristi Hospitals Wichita, Inc., Wichita, Kansas, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- University Hospitals Case Medical Center, Cleveland, Ohio, United States
- The Children's Medical Center of Dayton, Dayton, Ohio, United States
- Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
- West Virginia University Research Corporation, Morgantown, West Virginia, United States
Collaborators
Parexel
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01710644 on ClinicalTrials.govOther trials for Cystic fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT04530383Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel FunctionUniversity of Kansas Medical Center
- RECRUITINGPHASE2NCT07450547Phase 2 Study to Assess the Safety and Efficacy of ANG003Anagram Therapeutics, Inc.
- RECRUITINGPHASE1NCT07437105Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNANCT07436351ACT With CF Self-Help ToolkitThomas Jefferson University
- RECRUITINGNANCT07314229Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-IvacaftorUniversity Hospital, Lille
- RECRUITINGNCT07083557Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)Bettina Mittendorfer
- RECRUITINGNCT07369414Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at HomeResearch Center Borstel
- RECRUITINGNCT07505797ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)iSono Health, Inc.